黄秋菊

黄秋菊

  中药学博士，副教授。2018年博士毕业于广州中医药大学中药学专业，后在广州中医药大学中西医结合专业从事博士后研究工作。2021年9月入职广西医科大学药学院药理教研室。任中华中医药学会“粤港澳中青年中医药传承创新研讨会”常务委员。获2019年年度广东省科技进步一等奖。研究领域：肿瘤靶向药物研发；中药及其活性成分抗肿瘤新靶标的发现及机制研究。发表科研论文16篇，其中第一作者（或并列第一作者）SCI论文8篇。

    代表性课题（主持）：

(1) 广东省中医药防治肿瘤转化药学研究重点实验室开放课题，近红外荧光染料IR783缀合抗肿瘤药物FTS靶向治疗乳腺癌的靶标及分子机制研究，2019/1/1至2020/12/31，5万， 结题，主持。 

代表性论文（第一作者/通讯作者）：

(1) Huang, Qiuju#; Liao, Guochao#; Zhuang, Xuerong; Yang, Menglan; Yao, Jingjing; Deng, Jianhua; Zhang, Yanmin; Wang, Ying; Qi, Xiaoxiao; Pan, Dongfeng; Guan, Yang; Huang, Zhiying; Zhang, Fengxue;; Liu, Zhongqiu*; Lu, Linlin*; Ras inhibitor farnesylthiosalicylic acid conjugated with IR783 d ye exhibits improved tumor-targeting and altered anti-breast cancer mechanisms in mice, Acta Pharmacologica Sinica, 2021, 1-14. (一区，IF=7.169)

(2) Huang, Qiuju#; Feng, Lizhi#; Li, Hang; Zheng, Liang; Qi, Xiaoxiao; Wang, Ying; Feng, Qian;Liu, Zhongqiu;Liu, Xiaohong*; Lu, Linlin*. Jian-Pi-Bu-Xue-Formula Alleviates Cyclophosphamide-Ind uced Myelosuppression via Up-Regulating NRF2/HO1/NQO1 Signaling, Frontiers in Pharmacology, 2020, 11: 1302. (二区，IF=5.988)

(3) Wang, Wensheng#; Huang, Qiuju#（共同第一作者）; Chen, Yao; Huang, Zhiying; Huang, Yanfang; Wang, Ying; Qi, Xiaoxiao; Liu, Zhongqiu*; Lu, Linlin* et al. The novel FAT4 activator jujuboside A suppresses NSCLC tumo rigenesis by activating HIPPO signaling and inhibiting YAP nuclear translocation, Pharmacological Research, 2021, 170: 0-105723. (一区，IF=10.334)

(4) Liu, Zhenping; Chen, Jiamei; Huang Shuqing; Yan, Yu; Niu, Yue; Zeng, Junwei; Huang, Qiuju*（共同通讯）; Jin, Mingliang; Shui, Lingling*. Label-free biosensor for trace insulin-like growth factor-I assay based on rGO-SnS2 heterostructure nanocomposite. Sensors & Actuators: B. Chemical. 2022, 370:132415. (一区，IF=9.221)

(5) Liu, Zhenping #, Huang, Qiuju#（共同第一作者）, Chen, Jiamei; Yao, Jiyuan; Jin, Mingliang; Wang,Xin; Eser MetinAkinoglu; Zhang,Minmin; Li, Na; Shui, Lingling*. Nanoparticle-assisted sacrificial synthesis of hierarchical porous carbon composite for rapid sample enrichment and ultrasensitive label-free immunosensing of interleukin-6 biomarker. Journal of Electroanalytical Chemistry. 2021, 883: 115068. （二区, IF=4.598)

(6) Zheng, Hongming#; Huang, Qiuju#（共同第一作者）; Huang, Suchao; Yang, Xia; Zhu, Ting; Wang, Wensheng; Wang, Haojia; He, Shugui; Ji, Liyan; Wang, Ying; Qi, Xiaoxiao;Zhongqiu*; Lu, Linlin* et al. Senescence I nducer Shikonin ROS-Dependently Suppressed Lung Cancer Progression, Frontiers in Pharmacology, 20 18, 9: 0-519 (二区， IF=5.988)

(7) Feng, Lizhi#; Huang, Qiuju#（共同第一作者）; Huang, Zhiying; Li, Hang; Qi, Xiaoxiao; Wang, Ying; Liu, Zhong qiu; Xiaohong*; Lu, Linlin*. Optimized Animal Model of Cyclophosphamide-induced Bone Marrow S uppression, Basic and Clinical Pharmacology and Toxicology, 2016, 119(5): 428-435 (三区，IF=3.176)

(8) Huang, Qiuju, Huang, Jinxian; Zeng, Zhenhua; Luo, Jiani, Liu, Peiqing, Chen, Shaorui; Liu, Bing; Pan, Xuediao; Zang, Linquan; Zhou Sigui*, et al. Effects of ERK1/2/ PPARα / SCAD signal pathways on cardiomyocyte hypertrophy induced by Insulin-like growth factor 1 and phenylephrine. Life Sciences, 2015, 124: 41–49. (三区，IF=2.685)